HemaSphere (Aug 2023)

PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN-D5, A NOVEL BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS

  • Efstathios Kastritis,
  • Jeffrey Matous,
  • Jesus Berdeja,
  • Emad Abro,
  • Bradley Augustson,
  • Valentin Cabañas Perianes,
  • M. Theresa Cibeira,
  • Yael Cohen,
  • Michael Fong,
  • Moshe Gatt,
  • Veronica Gonzalez DE LA Calle,
  • Fiona Kwok,
  • Noa Lavi,
  • Hila Magen,
  • Albert Oriol,
  • Giovanni Palladini,
  • Keith Stockerl-Goldstein,
  • Taylor Eves,
  • Cheng Zheng,
  • Anthony Fiorino

DOI
https://doi.org/10.1097/01.HS9.0000975252.55444.26
Journal volume & issue
Vol. 7
p. e5544426

Abstract

Read online

No abstracts available.